首页> 外文期刊>National Journal of Medical Research >High Incidence of Advanced Stage Prostate Cancer in Riau Province of Indonesia
【24h】

High Incidence of Advanced Stage Prostate Cancer in Riau Province of Indonesia

机译:印度尼西亚廖内省晚期前列腺癌的高发病率

获取原文
       

摘要

Introduction: Indonesia is in the fifth position of the most prostate cancer incidence countries in Asia with the rate of 10.6 per 100.000 cases from all group of age and the mortality rate is about 8 per 100.000 cases. The objective of this study is to identify the characteristics of advanced stage prostate cancer patients. Materials and Methods: We reviewed the medical records of 42 advanced stage prostate cancer men of all 103 prostate cancer men in Arifin Achmad Regional General Hospital Pekanbaru Riau Province, Indo-nesia, from January 2010 to December 2016. Results: There were 103 adenocarcinoma of prostate patients from January 2010 to December 2016 consisting of 61 (59.2%) initial staging and 42 (40.8%) advanced stage prostate cancer patients in which included in this study. Most (40.5%) advanced stage prostate cancer patients were 61-70 years old. Most (88.1%) abnormal finding were found in digital rectal examination (DRE). Most (28.6%) patients had 61-80 ml prostate volume with Transrectal Ultrasound (TRUS). Most (47.6%) patients had initial Prostate Specific Antigen (PSA) 100 ng/ml with Gleason Score were mostly (81%) poorly differentiated. The bone scan results showed that 30 patients (71.4%) were positive for metastasis. The treatment with Androgen Deprivation Therapy (ADT) show the highest modality (78.6%). Conclusions: We found high incidence of advanced prostate cancers with high ages, high abnormality in DRE, high prostate volumes with TRUS, high PSA levels, high poorly differentiated adenocarsinomas, high Gleason Scores, high metastasis in bone scans and high treatment with ADTs.
机译:简介:印度尼西亚在亚洲所有前列腺癌发病率最高的国家中排名第五,在所有年龄段中,每100.000例中的比率为10.6,死亡率为每100.000例中约8例。这项研究的目的是确定晚期前列腺癌患者的特征。资料和方法:我们回顾了2010年1月至2016年12月在印度尼加拉瓜北肯巴鲁廖内省阿里芬·阿奇玛德地区总医院,对所有103名前列腺癌男性中的42名晚期前列腺癌男性的病历进行了分析。结果:共有103例腺癌2010年1月至2016年12月的前列腺癌患者包括61例(59.2%)初始分期和42例(40.8%)晚期前列腺癌患者,其中包括本研究。大多数(40.5%)晚期前列腺癌患者年龄为61-70岁。大多数(88.1%)异常发现是在直肠指检(DRE)中发现的。大多数(28.6%)患者经直肠超声(TRUS)的前列腺体积为61-80 ml。大多数(47.6%)患者的初始前列腺特异性抗原(PSA)> 100 ng / ml,格里森评分大多分化差(81%)。骨扫描结果显示30例(71.4%)转移阳性。雄激素剥夺疗法(ADT)的治疗表现出最高的治疗方式(78.6%)。结论:我们发现高年龄段,DRE高异常,TRUS的前列腺体积高,PSA水平高,分化差的腺癌肉瘤高,格里森评分高,骨扫描转移高和使用ADT进行治疗的晚期前列腺癌发病率高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号